46 related articles for article (PubMed ID: 33851100)
1. Epigenomic annotation of noncoding mutations identifies mutated pathways in primary liver cancer.
Lowdon RF; Wang T
PLoS One; 2017; 12(3):e0174032. PubMed ID: 28333948
[TBL] [Abstract][Full Text] [Related]
2. A full-proteome, interaction-specific characterization of mutational hotspots across human cancers.
Chen S; Liu Y; Zhang Y; Wierbowski SD; Lipkin SM; Wei X; Yu H
Genome Res; 2022 Jan; 32(1):135-149. PubMed ID: 34963661
[TBL] [Abstract][Full Text] [Related]
3. Identification of a growth hormone gene promoter repressor element and its cognate double- and single-stranded DNA-binding proteins.
Pan WT; Liu QR; Bancroft C
J Biol Chem; 1990 Apr; 265(12):7022-8. PubMed ID: 2324110
[TBL] [Abstract][Full Text] [Related]
4. Pan-Cancer Analysis of Mutation Hotspots in Protein Domains.
Miller ML; Reznik E; Gauthier NP; Aksoy BA; Korkut A; Gao J; Ciriello G; Schultz N; Sander C
Cell Syst; 2015 Sep; 1(3):197-209. PubMed ID: 27135912
[TBL] [Abstract][Full Text] [Related]
5. Developmental origins shape the paediatric cancer genome.
Chen X; Yang W; Roberts CWM; Zhang J
Nat Rev Cancer; 2024 Jun; 24(6):382-398. PubMed ID: 38698126
[TBL] [Abstract][Full Text] [Related]
6. A pan-cancer analysis of CpG Island gene regulation reveals extensive plasticity within Polycomb target genes.
Zheng Y; Huang G; Silva TC; Yang Q; Jiang YY; Koeffler HP; Lin DC; Berman BP
Nat Commun; 2021 Apr; 12(1):2485. PubMed ID: 33931649
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Value of PERK in Cancer and Its Relationship With Immune Cell Infiltration.
Wang P; Han L; Yu M; Cao Z; Li X; Shao Y; Zhu G
Front Mol Biosci; 2021; 8():648752. PubMed ID: 33937330
[No Abstract] [Full Text] [Related]
8. Pan-Cancer Analysis of FURIN as a Potential Prognostic and Immunological Biomarker.
Zhou B; Gao S
Front Mol Biosci; 2021; 8():648402. PubMed ID: 33968987
[TBL] [Abstract][Full Text] [Related]
9. Pan-cancer association of HLA gene expression with cancer prognosis and immunotherapy efficacy.
Schaafsma E; Fugle CM; Wang X; Cheng C
Br J Cancer; 2021 Aug; 125(3):422-432. PubMed ID: 33981015
[TBL] [Abstract][Full Text] [Related]
10. Pan-Cancer Analysis Reveals Distinct Metabolic Reprogramming in Different Epithelial-Mesenchymal Transition Activity States.
Sung JY; Cheong JH
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33917859
[TBL] [Abstract][Full Text] [Related]
11. Pan-Cancer Analysis of the Prognostic and Immunological Role of HSF1: A Potential Target for Survival and Immunotherapy.
Chen F; Fan Y; Cao P; Liu B; Hou J; Zhang B; Tan K
Oxid Med Cell Longev; 2021; 2021():5551036. PubMed ID: 34239690
[TBL] [Abstract][Full Text] [Related]
12. Integrating Clinical Cancer and PTM Proteomics Data Identifies a Mechanism of ACK1 Kinase Activation.
Balasooriya ER; Madhusanka D; López-Palacios TP; Eastmond RJ; Jayatunge D; Owen JJ; Gashler JS; Egbert CM; Bulathsinghalage C; Liu L; Piccolo SR; Andersen JL
Mol Cancer Res; 2024 Feb; 22(2):137-151. PubMed ID: 37847650
[TBL] [Abstract][Full Text] [Related]
13. Multimolecular characteristics and role of BRCA1 interacting protein C-terminal helicase 1 (BRIP1) in human tumors: a pan-cancer analysis.
Wang R; Zhang J; Cui X; Wang S; Chen T; Niu Y; Du X; Kong J; Wang L; Jiang Y
World J Surg Oncol; 2023 Mar; 21(1):91. PubMed ID: 36907870
[TBL] [Abstract][Full Text] [Related]
14. Widespread perturbation of ETS factor binding sites in cancer.
Carrasco Pro S; Hook H; Bray D; Berenzy D; Moyer D; Yin M; Labadorf AT; Tewhey R; Siggers T; Fuxman Bass JI
Nat Commun; 2023 Feb; 14(1):913. PubMed ID: 36808133
[TBL] [Abstract][Full Text] [Related]
15. Screening diagnostic markers for acute myeloid leukemia based on bioinformatics analysis.
Chen W; Liu D; Wang G; Pan Y; Wang S; Tang R
Transl Cancer Res; 2022 Jun; 11(6):1722-1729. PubMed ID: 35836534
[TBL] [Abstract][Full Text] [Related]
16. Pan-cancer noncoding genomic analysis identifies functional
He Z; Wu T; Wang S; Zhang J; Sun X; Tao Z; Zhao X; Li H; Wu K; Liu XS
iScience; 2021 Apr; 24(4):102285. PubMed ID: 33851100
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of recurrent CDC20 promoter variants in human melanoma.
Godoy PM; Oyedeji A; Mudd JL; Morikis VA; Zarov AP; Longmore GD; Fields RC; Kaufman CK
Commun Biol; 2023 Nov; 6(1):1216. PubMed ID: 38030698
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
